Schizophrenia Phenotype Preceding Behavioral Variant Frontotemporal Dementia Related to C9orf72 Repeat Expansion.


Journal

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology
ISSN: 1543-3641
Titre abrégé: Cogn Behav Neurol
Pays: United States
ID NLM: 101167278

Informations de publication

Date de publication:
06 2019
Historique:
entrez: 18 6 2019
pubmed: 18 6 2019
medline: 14 1 2020
Statut: ppublish

Résumé

Behavioral variant frontotemporal dementia (bvFTD) shares a constellation of clinical features with primary psychiatric disorders. The discovery of new FTD-related genetic mutations has brought attention to this overlap between bvFTD and psychotic disorders. The case reported here raises the question of whether C9orf72 repeat expansion may be involved in neuropsychiatric syndromes beyond the spectrum of neurodegenerative disease. A 61-year-old woman was referred to our memory clinic for behavioral changes and progressive cognitive decline over the last 3 years. Her medical history was significant for schizophrenia since age 36, with an exacerbation of psychotic symptoms at age 55, at which time she slowly worsened, became disorganized and apathetic, and presented new perseverative behaviors. Brain MRI showed mild bilateral frontal and temporal cortical atrophy, and F-fluorodeoxyglucose PET showed bilateral frontal and anterior temporal hypometabolism. Genetic analysis revealed C9orf72 hexanucleotide repeat expansion with more than 80 G4C2 repeats. Recently, FTD due to C9orf72 repeat expansion has been reported to show a high frequency of psychotic presentations. C9orf72 repeat expansion has previously been identified as a rare but possible cause of schizophrenia spectrum disorders. Our case report is characterized by a C9orf72-associated schizophrenia phenotype preceding bvFTD by 2 decades, which might reflect early prodromal neurodegeneration or neurodevelopmental and neurobiological effects of C9orf72 repeat expansion. Analysis of C9orf72 hexanucleotide repeat expansion may be appropriate in patients with schizophrenia spectrum disorders showing new behavioral and/or cognitive changes.

Identifiants

pubmed: 31205123
doi: 10.1097/WNN.0000000000000189
pii: 00146965-201906000-00005
doi:

Substances chimiques

C9orf72 Protein 0
C9orf72 protein, human 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

120-123

Auteurs

Leila Sellami (L)

Clinique Interdisciplinaire de Mémoire, Neurology Department, CHU de Québec, Faculté de médecine, Université Laval, Québec, QC, Canada.

Frédéric St-Onge (F)

Clinique Interdisciplinaire de Mémoire, Neurology Department, CHU de Québec, Faculté de médecine, Université Laval, Québec, QC, Canada.
CHU de Québec-Université Laval Research Center, Québec, QC, Canada.

Stéphane Poulin (S)

Clinique Interdisciplinaire de Mémoire, Neurology Department, CHU de Québec, Faculté de médecine, Université Laval, Québec, QC, Canada.

Robert Laforce (R)

Clinique Interdisciplinaire de Mémoire, Neurology Department, CHU de Québec, Faculté de médecine, Université Laval, Québec, QC, Canada.
CHU de Québec-Université Laval Research Center, Québec, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH